Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Appoints Jeb Keiper to Its Board of Directors

CAMBRIDGE, MASS. – [August 16, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of industry leader, Jeb Keiper, as an independent member of its Board of Directors. Mr. Keiper joins founder Michael Mendelsohn, M.D., Ken Novack, Ed Mascioli, M.D. […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content